CAS: 3565-72-8; 2-(1-(4-Bromophenyl)-1-Phenylethoxy)-N,N-Dimethylethan-1-Amine
- 英文名称2-(1-(4-Bromophenyl)-1-Phenylethoxy)-N,N-Dimethylethan-1-Amine
- 中文名称思布拉敏
- IUPAC名称2-(1-(4-bromophenyl)-1-phenylethoxy)-N,N-dimethylethan-1-amine
- 其它别名2-(4-Bromo-Alpha-Methylbenzhydryloxy)Ethyldimethylamine; 2-[(P-Bromo-α-Methyl-α-Phenylbenzyl)Oxy]-N,N-Dimethylethanamine; Ethanamine, 2-[1-(4-Bromophenyl)-1-Phenylethoxy]-N,N-Dimethyl-; 1-(2-Dimethylaminoethoxy)-1-(P-Bromophenyl)-1-Phenylethane; Embramine; 2-[(P-Bromo-α-Methyl-α-Phenylbenzyl)Oxy]-N,N-Dimethyl Ethylamine; 2-[1-(4-Bromophenyl)-1-Phenylethoxy]-N,N-Dimethylethanamine; Embramine Usp/ep/bp
- CAS编号3565-72-8
- MFCD编号:MFCD00869293
- FDA UNII编号:HH0KD7Z416
- 分子式:C18H22BrNO分子量:348.28
- 产品CID: 1364962
- 同类组份化合物CAS3565-72-8 (free base)21661-63-2 (teoclate)13977-28-1 (HCl)
- 产品分类有机原料 → 苯类化合物 → 苯和取代衍生物
物理性质
MSDS等安全信息
上下游产品
CAS号107-99-3 2-氯-N,N-二甲基乙胺合成工艺路线路线简述
📜2-氯-N,N-二甲基乙胺,Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于sodium Amide,苯体系中,化学反应生成思布拉敏
参考文献:Novak; Protiva,Collection Of Czechoslovak Chemical Communications,1959,Vol. 24,P. 3966,3974
标题:Novak; Protiva,Collection Of Czechoslovak Chemical Communications,1959,Vol. 24,P. 3966,3974
海关参考信息
- 2902600000-乙苯
2906210000-苄醇
2909110000-乙醚
2922110001-单乙醇胺 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:WO-2023075715-A1
优先权日:2021-10-26
标题 :A pharmaceutical formulation including leukotriene receptor antagonists and/or leukotriene synthesis inhibitors combined with non-steroidal anti-inflammatory drugs (nsaids)
发明人：OYTUN FARUK; CAN EFE
权利人:VSY BIYOTEKNOLOJI VE ILAC SANAYI ANONIM SIRKETI
摘要:This invention is related to a pharmaceutical formulation including Leukotriene receptor antagonists and/or Leukotriene synthesis inhibitors combined with non-steroidal anti-inflammatory drugs (NSAIDs) and antihistamines in ocular diseases and in inflammatory and allergic diseases for systemic and topical use. The objective of this invention is to create a novel formulation to be effective as much as steroids while having significantly less side effects for long-term use in treating ocular diseases, inflammatory and allergic diseases. In other words our aim is to achieve the inhibition of pro-inflammatory mediators (prostaglandins, thromboxane, histamine and leukotrienes) as much as steroids do with a safer combination.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
摘要:Collection of Czechoslovak Chemical Communications., 39(1366), 1974
📝 需求与反馈
尽可能描述清楚需求与问题信息
